Miromatrix to Report Second Quarter 2023 Financial Results
25 Luglio 2023 - 10:01PM
Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company
pioneering a novel technology for bioengineering fully
transplantable organs to help save and improve patients’ lives,
today announced that the Company will report financial results for
the second quarter 2023 after market close on Monday, August 14,
2023. Company management will host a corresponding conference call
beginning at 3:30 pm Central Time / 4:30 pm Eastern Time.
Individuals interested in listening to the conference call may
do so by dialing 866-652-5200 for domestic callers or 412-317-6060
for international callers. Please reference Conference ID:
10181369. To listen to a live webcast, please visit the investor
relations section of Miromatrix's website at:
https://miromatrix.gcs-web.com/
About MiromatrixMiromatrix Medical Inc. is
a life sciences company pioneering a novel technology for
bioengineering fully transplantable human organs to help save and
improve patients' lives. The Company has developed a proprietary
perfusion technology platform for bioengineering organs that it
believes will efficiently scale to address the shortage of
available human organs. The Company's initial development focus is
on human livers and kidneys. For more information,
visit miromatrix.com.
Investor ContactGreg Chodaczek347-620-7010
ir@miromatrix.com
Media Contact:press@miromatrix.com
Grafico Azioni MiroMatrix Medical (NASDAQ:MIRO)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni MiroMatrix Medical (NASDAQ:MIRO)
Storico
Da Giu 2023 a Giu 2024